DMAC - CIK 0001401040
The table below shows DiaMedica Therapeutics Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $15.65M | $3.02M | $4.54M | $4.73M | $4.71M | $7.41M |
| Short-term investments | $44.24M | $41.12M | $48.35M | $28.77M | $40.41M | $20.10M |
| Receivables | $258.00K | $236.00K | $369.00K | $82.00K | $130.00K | $340.00K |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $60.63M |
| $44.61M |
| $53.67M |
| $33.84M |
| $45.44M |
| $27.92M |
| Property, plant & equipment | $145.00K | $148.00K | $131.00K | $136.00K | $70.00K | $74.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $61.37M | $46.34M | $54.16M | $34.40M | $45.55M | $28.09M |
| Accounts payable | $1.48M | $940.00K | $926.00K | $734.00K | $509.00K | $1.10M |
| Total current liabilities | $5.13M | $5.39M | $2.79M | $2.17M | $1.52M | $2.03M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | -$172.77M | -$140.00M | -$115.56M | -$96.18M | -$82.50M | -$68.91M |
| Total equity | $56.11M | $40.72M | $51.06M | $31.83M | $44.02M | $26.01M |